Adverse events of interest following influenza vaccination in the first season of adjuvanted trivalent immunization: retrospective cohort study by de Lusignan, S, Tsang, RSM, Akinyemi, O, Lopez Bernal, J, Amirthalingam, G, Sherlock, J, Smith, G, Zambon, M, Howsam, G, Joy, M

Adverse events of interest following influenza vaccination, a comparison of cell culture-based with egg-based alternatives: English sentinel network annual report paper 2019/20 by de Lusignan, S, Tsang, RSM, Amirthalingam, G, Akinyemi, O, Sherlock, J, Tripathy, M, Deeks, A, Ferreira, F, Howsam, G, Hobbs, FDR, Joy, M

Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland by Simpson, CR, Kerr, S, Katikireddi, SV, McCowan, C, Ritchie, LD, Pan, J, Stock, SJ, Rudan, I, Tsang, RSM, de Lusignan, S, Hobbs, FDR, Akbari, A, Lyons, RA, Robertson, C, Sheikh, A

Development of a modified Cambridge Multimorbidity Score for use with SNOMED CT: an observational English primary care sentinel network study by Tsang, RSM, Joy, M, Whitaker, H, Sheppard, JP, Williams, J, Sherlock, J, Mayor, N, Meza-Torres, B, Button, E, Williams, AJ, Kar, D, Delanerolle, G, McManus, R, Hobbs, FDR, de Lusignan, S

Investigating the association between COVID-19 vaccination and care home outbreak frequency and duration by Bradley, DT, Murphy, S, McWilliams, P, Arnold, S, Lavery, S, Murphy, J, de Lusignan, S, Hobbs, R, Tsang, RSM, Akbari, A, Torabi, F, Beggs, J, Chuter, A, Shi, T, Vasileiou, E, Robertson, C, Sheikh, A, Reid, H, O'Reilly, D

Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self-controlled case series... by Tsang, RSM, Joy, M, Byford, R, Robertson, C, Anand, SN, Hinton, W, Mayor, N, Kar, D, Williams, J, Victor, W, Akbari, A, Bradley, DT, Murphy, S, O'Reilly, D, Owen, RK, Chuter, A, Beggs, J, Howsam, G, Sheikh, A, Hobbs, FDR, de Lusignan, S

Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups by Whitaker, HJ, Tsang, RSM, Byford, R, Andrews, NJ, Sherlock, J, Sebastian Pillai, P, Williams, J, Button, E, Campbell, H, Sinnathamby, M, Victor, W, Anand, S, Linley, E, Hewson, J, DArchangelo, S, Otter, AD, Ellis, J, Hobbs, RFD, Howsam, G, Zambon, M, Ramsay, M, Brown, KE, de Lusignan, S, Amirthalingam, G, Lopez Bernal, J

Disparities in the excess risk of mortality in the first wave of COVID-19: Cross sectional study of the English sentinel network by de Lusignan, S, Joy, M, Oke, J, McGagh, D, Nicholson, B, Sheppard, J, Akinyemi, O, Amirthalingam, G, Brown, K, Byford, R, Dabrera, G, Krajenbrink, E, Liyanage, H, LopezBernal, J, Okusi, C, Ramsay, M, Sherlock, J, Sinnathamby, M, Tsang, RSM, Brown, VT, Williams, J, Zambon, M, Ferreira, F, Howsam, G, Hobbs, R

Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in Englan... by Agrawal, U, Bedston, S, McCowan, C, Oke, J, Patterson, L, Robertson, C, Akbari, A, Azcoaga-Lorenzo, A, Bradley, DT, Fagbamigbe, AF, Grange, Z, Hall, ECR, Joy, M, Katikireddi, SV, Kerr, S, Ritchie, L, Murphy, S, Owen, RK, Rudan, I, Shah, SA, Simpson, CR, Torabi, F, Tsang, RSM, de Lusignan, S, Lyons, RA, O'Reilly, D, Sheikh, A

Risk of thrombocytopenic, haemorrhagic and thromboembolic disorders following COVID-19 vaccination and positive test: a self-controlled case series analysis in Wales by Torabi, F, Bedston, S, Lowthian, E, Akbari, A, Owen, RK, Bradley, DT, Agrawal, U, Collins, P, Fry, R, Griffiths, LJ, Beggs, J, Davies, G, Hollinghurst, J, Lyons, J, Abbasizanjani, H, Cottrell, S, Perry, M, Roberts, R, Azcoaga-Lorenzo, A, Fagbamigbe, AF, Shi, T, Tsang, RSM, Robertson, C, Hobbs, FDR, de Lusignan, S, McCowan, C, Gravenor, M, Simpson, CR, Sheikh, A, Lyons, RA

COVID-19 vaccine effectiveness against hospitalisation and death of people in clinical risk groups during the Delta variant period: English primary care network cohort study by Whitaker, HJ, Tsang, RSM, Byford, R, Aspden, C, Button, E, Sebastian Pillai, P, Jamie, G, Kar, D, Williams, J, Sinnathamby, M, Marsden, G, Elson, WH, Leston, M, Anand, S, Okusi, C, Fan, X, Linley, E, Rowe, C, DArcangelo, S, Otter, AD, Ellis, J, Hobbs, FDR, Tzortziou-Brown, V, Zambon, M, Ramsay, M, Brown, KE, Amirthalingam, G, Andrews, NJ, de Lusignan, S, Lopez Bernal, J

First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland by Simpson, CR, Shi, T, Vasileiou, E, Katikireddi, SV, Kerr, S, Moore, E, McCowan, C, Agrawal, U, Shah, SA, Ritchie, LD, Murray, J, Pan, J, Bradley, DT, Stock, SJ, Wood, R, Chuter, A, Beggs, J, Stagg, HR, Joy, M, Tsang, RSM, de Lusignan, S, Hobbs, R, Lyons, RA, Torabi, F, Bedston, S, O'Leary, M, Akbari, A, McMenamin, J, Robertson, C, Sheikh, A

Effectiveness of first dose of COVID-19 vaccines against hospital admissions in Scotland: National prospective cohort study of 5.4 million people by Vasileiou, E, Simpson, CR, Robertson, C, Shi, T, Kerr, S, Agrawal, U, Akbari, A, Bedston, S, Beggs, J, Bradley, D, Chuter, A, de Lusignan, S, Docherty, A, Ford, D, Hobbs, R, Joy, M, Katikireddi, SV, Marple, J, McCowan, C, McGagh, D, McMenamin, J, Moore, E, Murray, J-LK, Pan, J, Ritchie, L, Shah, SA, Stock, S, Torabi, F, Tsang, RSM, Wood, R, Woolhouse, M, Sheikh, A

First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: a pooled self-controlled case series study of 11.6 million individuals in England, Scotl... by Kerr, S, Joy, M, Torabi, F, Bedston, S, Akbari, A, Agrawal, U, Beggs, J, Bradley, D, Chuter, A, Docherty, AB, Ford, D, Hobbs, R, Katikireddi, SV, Lowthian, E, de Lusignan, S, Lyons, R, Marple, J, McCowan, C, McGagh, D, McMenamin, J, Moore, E, Murray, J-LK, Owen, RK, Pan, J, Ritchie, L, Shah, SA, Shi, T, Stock, S, Tsang, RSM, Vasileiou, E, Woolhouse, M, Simpson, CR, Robertson, C, Sheikh, A